E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
[20-Hydroxyecdysone--plant adaptogen: an anabolic effect, possible use in sports nutrition].
Volodin, V V, Sidorova, Iu S, Mazo, V K · Voprosy pitaniia · 2013
Quick Summary
This review discusses 20-hydroxyecdysone, a compound found in plants that may help the body become more resistant to stress. The authors suggest it could reduce fatigue and improve memory and attention, and propose it as a possible supplement for athletes and people with chronic fatigue.
Why It Matters
ME/CFS patients experience persistent, debilitating fatigue and cognitive dysfunction resistant to conventional treatments. If phytoecdysteroids could reduce stress mediator overactivation and improve energy metabolism, they might represent a novel therapeutic approach; however, rigorous human clinical trials would be needed to establish safety and efficacy in this population.
Observed Findings
- Animal studies demonstrate anabolic effects of 20-hydroxyecdysone
- Phytoecdysteroids are structurally similar to glucocorticoids
- Adaptogens are proposed to reduce excessive stress mediator elevation during stress exposure
- Scientific publications reference applications in chronic fatigue syndrome and neuromuscular fatigue
- Polyhydroxylated sterols show adaptogenic properties in preclinical research
Inferred Conclusions
- 20-hydroxyecdysone may enhance non-specific stress resistance through normalization of stress mediator responses
- Phytoecdysteroids warrant investigation as potential components of nutritional supplements for fatigue management
- Adaptogenic compounds could theoretically improve cognitive function and reduce muscle fatigue
- Further research may support use of 20-hydroxyecdysone in sports nutrition and chronic fatigue applications
Remaining Questions
- What are the mechanisms by which 20-hydroxyecdysone normalizes stress mediator responses in humans with ME/CFS?
- Have randomized controlled trials been conducted to assess efficacy and safety in ME/CFS patient populations?
What This Study Does Not Prove
This review does not establish clinical efficacy of 20-hydroxyecdysone in ME/CFS patients—it presents only anecdotal references to potential applications without controlled human trials. The mechanism of action proposed (stress mediator normalization) is largely hypothetical and has not been validated in the ME/CFS population. Animal studies of anabolic effects do not necessarily translate to therapeutic benefit in human disease.
Tags
Symptom:Cognitive DysfunctionFatigue
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- PMID
- 24741953
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →